Given that arginase can regulate NO production in endothelial cells by competing with eNOS for the substrate L-arginine [40, 41], it is plausible that IL-1β may contribute to endothelial dysfunction by limiting arginine availability for eNOS via increases in arginase activity. The gene discussed is NOS3; the disease is endothelial dysfunction.